Concepedia

Author

Monique R. Bidell

Albany College of Pharmacy and Health SciencesORCID

Also Known As

M.R. Bidell, Monique Bidell, Monique R Bidell, Monique R. Bidell, Monique R. Bidell,

32

Publications

903

Citations

15

H-Index

14

Concepts

All Affiliations

Albany College of Pharmacy and Health SciencesHarvard UniversityMerck & Co., Inc., Rahway, NJ, USA (United States)Massachusetts General HospitalMidwestern University
MR

About

Monique R. Bidell is an author at Albany College of Pharmacy and Health Sciences specializing in antimicrobial resistance, infection control, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

83

2

Health Sciences

1

1

68

3

Epidemiology

1

1

68

4

Hospital Medicine

1

1

68

5

Antibiotics

1

1

15

Monique R. Bidell

×

7

Publications

266

Citations

7

H-Index

YearCitations

Colistin Nephrotoxicity: Meta-Analysis of Randomized Controlled Trials

Khalid Eljaaly, Monique R. Bidell, Ronak G. Gandhi,

Open Forum Infectious Diseases

2021

77

Fluoroquinolone and Third-Generation-Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region?

Monique R. Bidell, Melissa Palchak, John Mohr,

Antimicrobial Agents and Chemotherapy

2016

68

Characterization of the haematological profile of 21 days of tedizolid in healthy subjects

Thomas P. Lodise, Monique R. Bidell, Shawn D. Flanagan,

Journal of Antimicrobial Chemotherapy

2016

42

Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study

Natalie J. Atallah, Hailey M. Warren, Matthew B. Roberts,

PLoS ONE

2022

38

Effect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of key Gram-negative pathogens among patients with hospital-onset urinary tract infections

Monique R. Bidell, Melissa Palchak Opraseuth, Min Yoon,

BMC Infectious Diseases

2017

16

Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5 mg/L: A pilot study

Dmitriy M. Martirosov, Monique R. Bidell, Manjunath P. Pai,

Diagnostic Microbiology and Infectious Disease

2017

15

Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study

Dmitriy M. Martirosov, Monique R. Bidell, Manjunath P. Pai,

BMC Infectious Diseases

2017

10

Page 1